Exagen, Inc. (XGN)
4.26
-0.01
(-0.23%)
USD |
NASDAQ |
May 22, 16:00
4.29
+0.03
(+0.70%)
After-Hours: 20:00
Exagen Cash from Investing (Quarterly) : -0.228M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Veracyte, Inc. | -127.96M |
| Insight Molecular Diagnostics, Inc. | -0.613M |
| bioAffinity Technologies, Inc. | -0.0057M |
| GRAIL, Inc. | -93.44M |
| FONAR Corp. | -0.173M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.42M |
| Cash from Financing (Quarterly) | -0.062M |
| Free Cash Flow | -14.13M |
| Free Cash Flow Per Share (Quarterly) | -0.4462 |
| Free Cash Flow to Equity (Quarterly) | -10.12M |
| Free Cash Flow to Firm (Quarterly) | -9.366M |
| Free Cash Flow Yield | -14.50% |